Form 4 holding
Director, 10%+ Owner
Generate Biomedicines, Inc.
- Security class
- Common Stock
- Shares / value
- 25,016,458
- Estimated value
- Report date
- 26 Feb 2026
- Price
- Ownership
- By Flagship VentureLabs VI, LLC
Ph.D. Noubar B. Afeyan - Director, 10%+ Owner at Generate Biomedicines, Inc.
Insider Transactions and Holdings
- Entity type
- Individual
- Role
- Director, 10%+ Owner
- Issuer symbol
- GENB on Nasdaq
- Source filings
- Open source filing history
Identity
Issuer context
SEC evidence
There are no Buy or Sell transactions made by Ph.D. Noubar B. Afeyan since 01 Jun 2025
Holdings reported by Ph.D. Noubar B. Afeyan for Generate Biomedicines, Inc.
Form 4 holding
Director, 10%+ Owner
Generate Biomedicines, Inc.
- Security class
- Common Stock
- Shares / value
- 15,264,724
- Estimated value
- Report date
- 02 Mar 2026
- Price
- Ownership
- By Flagship Pioneering Fund VII, L.P.
Form 4 holding
Director, 10%+ Owner
Generate Biomedicines, Inc.
- Security class
- Common Stock
- Shares / value
- 12,723,940
- Estimated value
- Report date
- 02 Mar 2026
- Price
- Ownership
- By Flagship Pioneering Fund VI, L.P.
Form 4 holding
Director, 10%+ Owner
Generate Biomedicines, Inc.
- Security class
- Common Stock
- Shares / value
- 4,340,252
- Estimated value
- Report date
- 02 Mar 2026
- Price
- Ownership
- By FPN II, L.P.
Form 4 holding
Director, 10%+ Owner
Generate Biomedicines, Inc.
- Security class
- Common Stock
- Shares / value
- 2,777,752
- Estimated value
- Report date
- 02 Mar 2026
- Price
- Ownership
- By Flagship Pioneering Special Opportunities Fund II, L.P.
Form 4 holding
Director, 10%+ Owner
Generate Biomedicines, Inc.
- Security class
- Common Stock
- Shares / value
- 1,562,500
- Estimated value
- Report date
- 02 Mar 2026
- Price
- Ownership
- By Pioneering Medicines 02, LLC
Form 4 holding
Director, 10%+ Owner
Generate Biomedicines, Inc.
- Security class
- Common Stock
- Shares / value
- 987,491
- Estimated value
- Report date
- 02 Mar 2026
- Price
- Ownership
- By Nutritional Health LTP Fund, L.P.
Form 4 holding
Director, 10%+ Owner
Generate Biomedicines, Inc.
- Security class
- Stock Option (Right to Buy)
- Shares / value
- 29,561
- Estimated value
- Report date
- 26 Feb 2026
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Form 4 holding
Director, 10%+ Owner
Generate Biomedicines, Inc.
- Security class
- Series A Preferred Stock
- Shares / value
- 0
- Estimated value
- Report date
- 02 Mar 2026
- Price
- Ownership
- By Flagship Pioneering Fund VII, L.P.
- Underlying class
- Common Stock
- Underlying amount
Form 4 holding
Director, 10%+ Owner
Generate Biomedicines, Inc.
- Security class
- Series A Preferred Stock
- Shares / value
- 0
- Estimated value
- Report date
- 02 Mar 2026
- Price
- Ownership
- By Flagship Pioneering Fund VI, L.P.
- Underlying class
- Common Stock
- Underlying amount
Form 4 holding
Director, 10%+ Owner
Generate Biomedicines, Inc.
- Security class
- Series A Preferred Stock
- Shares / value
- 0
- Estimated value
- Report date
- 02 Mar 2026
- Price
- Ownership
- By Nutritional Health LTP Fund, L.P.
- Underlying class
- Common Stock
- Underlying amount
Form 4 holding
Director, 10%+ Owner
Generate Biomedicines, Inc.
- Security class
- Series B Preferred Stock
- Shares / value
- 0
- Estimated value
- Report date
- 02 Mar 2026
- Price
- Ownership
- By Flagship Pioneering Fund VII, L.P.
- Underlying class
- Common Stock
- Underlying amount
Form 4 holding
Director, 10%+ Owner
Generate Biomedicines, Inc.
- Security class
- Series B Preferred Stock
- Shares / value
- 0
- Estimated value
- Report date
- 02 Mar 2026
- Price
- Ownership
- By Flagship Pioneering Fund VI, L.P.
- Underlying class
- Common Stock
- Underlying amount
Form 4 holding
Director, 10%+ Owner
Generate Biomedicines, Inc.
- Security class
- Series B Preferred Stock
- Shares / value
- 0
- Estimated value
- Report date
- 02 Mar 2026
- Price
- Ownership
- By Flagship Pioneering Special Opportunities Fund II, L.P.
- Underlying class
- Common Stock
- Underlying amount
Form 4 holding
Director, 10%+ Owner
Generate Biomedicines, Inc.
- Security class
- Series B Preferred Stock
- Shares / value
- 0
- Estimated value
- Report date
- 02 Mar 2026
- Price
- Ownership
- By FPN II, L.P.
- Underlying class
- Common Stock
- Underlying amount
Form 4 holding
Director, 10%+ Owner
Generate Biomedicines, Inc.
- Security class
- Series C Preferred Stock
- Shares / value
- 0
- Estimated value
- Report date
- 02 Mar 2026
- Price
- Ownership
- By Flagship Pioneering Fund VII, L.P.
- Underlying class
- Common Stock
- Underlying amount
Form 4 holding
Director, 10%+ Owner
Generate Biomedicines, Inc.
- Security class
- Series C Preferred Stock
- Shares / value
- 0
- Estimated value
- Report date
- 02 Mar 2026
- Price
- Ownership
- By Flagship Pioneering Special Opportunities Fund II, L.P.
- Underlying class
- Common Stock
- Underlying amount
Form 4 holding
Director, 10%+ Owner
Generate Biomedicines, Inc.
- Security class
- Series C Preferred Stock
- Shares / value
- 0
- Estimated value
- Report date
- 02 Mar 2026
- Price
- Ownership
- By FPN II, L.P.
- Underlying class
- Common Stock
- Underlying amount
Transactions reported by Ph.D. Noubar B. Afeyan for Generate Biomedicines, Inc.
| Sym | Class | Transaction | % | Reported value | Reported price | Shares | Shares after | Date | Ownership |
|---|
* indicates a reported price that failed the local validity check.